BACKGROUND: The main clinical determinants of quality of life (QOL) 5 years after clinically isolated syndrome (CIS) are Expanded Disability Status Scale (EDSS) score and conversion to clinically definite multiple sclerosis (CDMS). The aim of this study was to determine the demographic, clinical, and magnetic resonance imaging (MRI) factors associated with QOL 10 years after CIS. METHODS: Controlled High Risk Avonex® Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS) 10-year patients were assessed for CDMS, EDSS score, MRI T2 activity, brain parenchymal fraction, and patient-reported QOL. Associations were evaluated using analysis of variance models. RESULTS: A second clinical event consistent with CDMS and h...
The association of pathology and neurological deficit with quality of life (QoL) in multiple scleros...
Background: Quantifying the clinical impact of multiple sclerosis (MS) is one of the most important ...
Objectives: To explore whether time to diagnosis, time to treatment initiation and age to reach disa...
BACKGROUND AND OBJECTIVES: A few studies have found that low scores on self-rated health and qualit...
International audienceCognition and health-related quality of life (HRQoL) are early involved in mul...
OBJECTIVE: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Objective: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Background: Evidence on the progress of disease severity in Multiple Sclerosis (MS) is generally lim...
BACKGROUND: Little is known about quality of life (QOL) at the time of multiple sclerosis (MS) or cl...
International audienceINTRODUCTION: Knowledge of which factors are determinant of quality of life (Q...
The association of pathology and neurological deficit with quality of life (QoL) in multiple scleros...
Background: Quantifying the clinical impact of multiple sclerosis (MS) is one of the most important ...
Objectives: To explore whether time to diagnosis, time to treatment initiation and age to reach disa...
BACKGROUND AND OBJECTIVES: A few studies have found that low scores on self-rated health and qualit...
International audienceCognition and health-related quality of life (HRQoL) are early involved in mul...
OBJECTIVE: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Objective: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Background: Evidence on the progress of disease severity in Multiple Sclerosis (MS) is generally lim...
BACKGROUND: Little is known about quality of life (QOL) at the time of multiple sclerosis (MS) or cl...
International audienceINTRODUCTION: Knowledge of which factors are determinant of quality of life (Q...
The association of pathology and neurological deficit with quality of life (QoL) in multiple scleros...
Background: Quantifying the clinical impact of multiple sclerosis (MS) is one of the most important ...
Objectives: To explore whether time to diagnosis, time to treatment initiation and age to reach disa...